Welcome to our dedicated page for Ewellness Health news (Ticker: EWLL), a resource for investors and traders seeking the latest updates and insights on Ewellness Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ewellness Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ewellness Health's position in the market.
eWellness Healthcare Corporation (OTC: PK EWLL) has shifted its primary focus from American Health Protection Inc. to acquiring ArtFin Inc., a publicly traded NFT marketplace. This strategic pivot aims to leverage the expertise of CEO Ed Honor in overseeing the NFT sector. The NFT market has seen sales reach $39 billion, with weekly transactions between $10-20 million. ArtFin provides comprehensive services for NFT creation and sales, supporting multiple blockchains. The company plans to apply for a name change to ArtFin and will undergo a 1/2000 reverse stock split by March 2022.
The merger between American Health Protection and EWLL signifies a strategic move to become a leading supplier of Hypochlorous Acid, a popular disinfectant. The company aims to leverage Tritanium Labs' low-cost production capability, forecasting the disinfectant market to reach $1.5 billion by 2027. The merger will allow EWLL to change its name to American Health Protection Corp. and enhance its market position with a nationwide franchising operation. The company expects to be fully compliant with reporting obligations by August 2021, positioning it for significant growth in the post-pandemic environment.
eWellness Healthcare Corporation (EWLL) is merging with American Health Protection Inc. (AMHP), aiming to be a key player in the hypochlorous acid market, anticipated to reach $1.5 billion by 2027. AMHP plans to leverage its partnership with Tritanium Labs to produce hypochlorous acid at a lower cost, aiming for strong market penetration through a franchising model. The merger also includes a proposed reverse stock split of 1:2000. eWellness is optimistic about meeting SEC reporting and benefiting from pandemic-related funding for domestic PPE producers.
FAQ
What is the current stock price of Ewellness Health (EWLL)?
What is the market cap of Ewellness Health (EWLL)?
